Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

7 Answers to FAQs About the New SEC Guidance for Draft Registration Statements

Securities Law Exchange Blog


August 23, 2017

Last week, the SEC's Division of Corporation Finance issued updated guidance on processing procedures for draft registration statements. Below are seven frequently asked questions related to the new guidance:

  • Do we have the ability to confidentially submit a draft registration statement(s) in connection with our IPO or within 12 months of the effective date of the IPO registration statement?
  • What standard should we use when determining whether financial information can be excluded?
  • What is the deadline for publicly filing my registration statement?
  • What annual and interim financial information may be excluded from the registration statement?
  • What is an example of the financial statement policy?
  • Can we omit financial statements of other entities from our filing or submission?
  • Does the FAST Act and updated Corp Fin policy regarding the omission of certain financials also apply to pro forma financials under Article 11 of Regulation S-X?
Securities Law Exchange Blog

To continue reading this article on the firm's Securities Law Exchange blog, please click here to read the FAQ summary table on the new SEC guidance for draft registration statements.

Bass, Berry & Sims' Securities Law Exchange blog features commentary and practical insight on SEC updates for publicly traded companies.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.